PMID- 27431267 OWN - NLM STAT- MEDLINE DCOM- 20180710 LR - 20181113 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 6 DP - 2016 Jul 19 TI - Comparative chemical array screening for p38gamma/delta MAPK inhibitors using a single gatekeeper residue difference between p38alpha/beta and p38gamma/delta. PG - 29881 LID - 10.1038/srep29881 [doi] LID - 29881 AB - Mammalian p38 mitogen activated protein kinases (MAPKs) are responsive to a variety of cellular stresses. The development of specific pyridinyl imidazole inhibitors has permitted the characterization of the p38 MAPK isoform p38alpha, which is expressed in most cell types, whereas the physiological roles of p38gamma and p38delta are poorly understood. In this study, we report an approach for identifying selective inhibitors against p38gamma and p38delta by focusing on the difference in gatekeeper residues between p38alpha/beta and p38gamma/delta. Using GST-fused p38alpha wild type and T106M mutant constructs, wherein the p38alpha gatekeeper residue (Thr-106) was substituted by the p38gamma/delta-type (Met), we performed comparative chemical array screening to identify specific binders of the mutant and identified SU-002 bound to p38alphaT106M specifically. SU-002 was found to inhibit p38alphaT106M but not p38alpha kinase activity in in vitro kinase assays. SU-005, the analog of SU-002, had inhibitory effects against the kinase activity of p38gamma and p38delta in vitro but not p38alpha. In addition, SU-005 inhibited both p38gamma and p38delta auto-phosphorylation in HeLa and HEK293T cells. These results demonstrate that the comparative chemical array screening approach is a powerful technique to explore specific inhibitors for mutant proteins with even single amino-acid substitutions in a high-throughput manner. FAU - Kondoh, Yasumitsu AU - Kondoh Y AD - Antibiotics Laboratory, RIKEN, Saitama 351-0198, Japan. AD - Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Saitama 351-0198, Japan. FAU - Honda, Kaori AU - Honda K AD - Bio-Active Compounds Discovery Research Unit, RIKEN Center for Sustainable Resource Science, Saitama 351-0198, Japan. FAU - Hiranuma, Sayoko AU - Hiranuma S AD - Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Saitama 351-0198, Japan. FAU - Hayashi, Teruo AU - Hayashi T AD - Antibiotics Laboratory, RIKEN, Saitama 351-0198, Japan. FAU - Shimizu, Takeshi AU - Shimizu T AD - Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Saitama 351-0198, Japan. FAU - Watanabe, Nobumoto AU - Watanabe N AD - Bio-Active Compounds Discovery Research Unit, RIKEN Center for Sustainable Resource Science, Saitama 351-0198, Japan. FAU - Osada, Hiroyuki AU - Osada H AD - Antibiotics Laboratory, RIKEN, Saitama 351-0198, Japan. AD - Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science, Saitama 351-0198, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160719 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Imidazoles) RN - 0 (Protein Isoforms) RN - 0 (Protein Kinase Inhibitors) RN - 7GBN705NH1 (imidazole) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - *Drug Evaluation, Preclinical MH - HEK293 Cells MH - HeLa Cells MH - Humans MH - Imidazoles/chemistry/pharmacology MH - Phosphorylation MH - Protein Isoforms/*antagonists & inhibitors/genetics MH - Protein Kinase Inhibitors/chemistry/*pharmacology MH - p38 Mitogen-Activated Protein Kinases/*antagonists & inhibitors/genetics PMC - PMC4949465 EDAT- 2016/07/20 06:00 MHDA- 2018/07/11 06:00 PMCR- 2016/07/19 CRDT- 2016/07/20 06:00 PHST- 2016/02/18 00:00 [received] PHST- 2016/06/23 00:00 [accepted] PHST- 2016/07/20 06:00 [entrez] PHST- 2016/07/20 06:00 [pubmed] PHST- 2018/07/11 06:00 [medline] PHST- 2016/07/19 00:00 [pmc-release] AID - srep29881 [pii] AID - 10.1038/srep29881 [doi] PST - epublish SO - Sci Rep. 2016 Jul 19;6:29881. doi: 10.1038/srep29881.